These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11233456)

  • 1. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
    Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
    Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM; Russell JM; Delgado PL; Fawcett J; Friedman RA; Harrison WM; Koran LM; Miller IW; Thase ME; Howland RH; Connolly MA; Miceli RJ
    J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM; Kornstein SG; Shea MT; McCullough JP; Harrison WM; Hirschfeld RM; Keller MB
    J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
    Forlenza OV; Almeida OP; Stoppe A; Hirata ES; Ferreira RCR
    Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
    Miller IW; Keitner GI; Schatzberg AF; Klein DN; Thase ME; Rush AJ; Markowitz JC; Schlager DS; Kornstein SG; Davis SM; Harrison WM; Keller MB
    J Clin Psychiatry; 1998 Nov; 59(11):608-19. PubMed ID: 9862607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U; Arató M; Zhu Y; Austin C
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
    Feiger AD; Flament MF; Boyer P; Gillespie JA
    Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E; González de Chávez M; García-Toro M; Pérez-Arnau F; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline treatment of major depression in patients with acute MI or unstable angina.
    Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
    JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline versus imipramine to prevent relapse in chronic depression.
    Koran LM; Gelenberg AJ; Kornstein SG; Howland RH; Friedman RA; DeBattista C; Klein D; Kocsis JH; Schatzberg AF; Thase ME; Rush AJ; Hirschfeld RM; LaVange LM; Keller MB
    J Affect Disord; 2001 Jun; 65(1):27-36. PubMed ID: 11426506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E
    BMJ; 2015 Sep; 351():h4320. PubMed ID: 26376805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.